Skip to main content
High RiskFDAfda-F-0624-2025UNDECLARED ALLERGEN

Green Chile Bean Burrito, 15 days refrigerated at 33 45 degrees Fahrenheit. 120 days frozen at or below 32 degrees Fahrenheit. Packag...

Category
Units Affected
350
Recall Date
December 27, 2024
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0624-2025.

Milk not listed in the ingredients or included in parentheses after American Cheese.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0624-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Mi Ranchito Foods, Incorporated or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0624-2025.

Mi Ranchito Foods, Incorporated

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Mi Ranchito Foods, Incorporated Recall FAQ

Mi Ranchito Foods, Incorporated is the subject of a frozen food safety report: Green Chile Bean Burrito, 15 days refrigerated at 33 45 degrees Fahrenheit. 120 days frozen at or below 32 degrees Fahrenheit. Packag.... The notice was published on December 27, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 350 units are potentially affected.